vs
Esperion Therapeutics, Inc.（ESPR）与FULTON FINANCIAL CORP（FULT）财务数据对比。点击上方公司名可切换其他公司
FULTON FINANCIAL CORP的季度营收约是Esperion Therapeutics, Inc.的2.0倍（$336.2M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 4.2%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 0.2%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
富尔顿金融公司是美国的区域性金融服务控股企业，总部位于宾夕法尼亚州兰开斯特市，主要为当地及周边区域提供多元化的金融相关服务，在区域金融市场拥有稳定的业务布局。
ESPR vs FULT — 直观对比
营收规模更大
FULT
是对方的2.0倍
$168.4M
营收增速更快
ESPR
高出139.5%
4.2%
两年增速更快
ESPR
近两年复合增速
0.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $336.2M |
| 净利润 | — | $94.8M |
| 毛利率 | — | — |
| 营业利润率 | 50.6% | — |
| 净利率 | — | 28.2% |
| 营收同比 | 143.7% | 4.2% |
| 净利润同比 | — | 1.9% |
| 每股收益（稀释后） | $0.32 | $0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRFULT
| Q1 26 | — | $336.2M | ||
| Q4 25 | $168.4M | $336.0M | ||
| Q3 25 | $87.3M | $334.6M | ||
| Q2 25 | $82.4M | $324.1M | ||
| Q1 25 | $65.0M | $318.4M | ||
| Q4 24 | $69.1M | $319.6M | ||
| Q3 24 | $51.6M | $317.7M | ||
| Q2 24 | $73.8M | $334.7M |
净利润ESPRFULT
| Q1 26 | — | $94.8M | ||
| Q4 25 | — | $99.0M | ||
| Q3 25 | $-31.3M | $100.5M | ||
| Q2 25 | $-12.7M | $99.2M | ||
| Q1 25 | $-40.5M | $93.0M | ||
| Q4 24 | — | $68.6M | ||
| Q3 24 | $-29.5M | $63.2M | ||
| Q2 24 | $-61.9M | $95.0M |
营业利润率ESPRFULT
| Q1 26 | — | — | ||
| Q4 25 | 50.6% | 35.7% | ||
| Q3 25 | -11.4% | 38.2% | ||
| Q2 25 | 8.6% | 37.8% | ||
| Q1 25 | -34.0% | 36.1% | ||
| Q4 24 | -6.4% | 27.0% | ||
| Q3 24 | -31.0% | 25.1% | ||
| Q2 24 | 3.5% | 30.8% |
净利率ESPRFULT
| Q1 26 | — | 28.2% | ||
| Q4 25 | — | 29.5% | ||
| Q3 25 | -35.9% | 30.0% | ||
| Q2 25 | -15.4% | 30.6% | ||
| Q1 25 | -62.2% | 29.2% | ||
| Q4 24 | — | 21.5% | ||
| Q3 24 | -57.2% | 19.9% | ||
| Q2 24 | -83.9% | 28.4% |
每股收益（稀释后）ESPRFULT
| Q1 26 | — | $0.55 | ||
| Q4 25 | $0.32 | $0.53 | ||
| Q3 25 | $-0.16 | $0.53 | ||
| Q2 25 | $-0.06 | $0.53 | ||
| Q1 25 | $-0.21 | $0.49 | ||
| Q4 24 | $-0.14 | $0.36 | ||
| Q3 24 | $-0.15 | $0.33 | ||
| Q2 24 | $-0.33 | $0.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $3.5B |
| 总资产 | $465.9M | $32.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRFULT
| Q1 26 | — | — | ||
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $86.1M | — | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | — | ||
| Q3 24 | $144.7M | — | ||
| Q2 24 | $189.3M | — |
股东权益ESPRFULT
| Q1 26 | — | $3.5B | ||
| Q4 25 | $-302.0M | $3.5B | ||
| Q3 25 | $-451.4M | $3.4B | ||
| Q2 25 | $-433.5M | $3.3B | ||
| Q1 25 | $-426.2M | $3.3B | ||
| Q4 24 | $-388.7M | $3.2B | ||
| Q3 24 | $-370.2M | $3.2B | ||
| Q2 24 | $-344.2M | $3.1B |
总资产ESPRFULT
| Q1 26 | — | $32.2B | ||
| Q4 25 | $465.9M | $32.1B | ||
| Q3 25 | $364.0M | $32.0B | ||
| Q2 25 | $347.1M | $32.0B | ||
| Q1 25 | $324.0M | $32.1B | ||
| Q4 24 | $343.8M | $32.1B | ||
| Q3 24 | $314.1M | $32.2B | ||
| Q2 24 | $352.3M | $31.8B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESPRFULT
| Q1 26 | — | — | ||
| Q4 25 | $45.2M | $304.5M | ||
| Q3 25 | $-4.3M | $116.1M | ||
| Q2 25 | $-31.4M | $91.7M | ||
| Q1 25 | $-22.6M | $703.0K | ||
| Q4 24 | $-35.0M | $416.6M | ||
| Q3 24 | $-35.3M | $-22.0M | ||
| Q2 24 | $-7.2M | $157.8M |
自由现金流ESPRFULT
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | — | ||
| Q2 24 | $-7.3M | — |
自由现金流率ESPRFULT
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | — | ||
| Q2 24 | -9.9% | — |
资本支出强度ESPRFULT
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — |
现金转化率ESPRFULT
| Q1 26 | — | — | ||
| Q4 25 | — | 3.08× | ||
| Q3 25 | — | 1.16× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 6.07× | ||
| Q3 24 | — | -0.35× | ||
| Q2 24 | — | 1.66× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
FULT
暂无分部数据
